基于国民健康保险服务数据库的韩国老年人永久性血管通路的结果评估

IF 16.4 1区 化学 Q1 CHEMISTRY, MULTIDISCIPLINARY
Hyangkyoung Kim, Hoon Suk Park, Tae Hyun Ban, Seung Boo Yang, Young joo Kwon, the vascular access working group of the Korean Society of Dialysis Access
{"title":"基于国民健康保险服务数据库的韩国老年人永久性血管通路的结果评估","authors":"Hyangkyoung Kim,&nbsp;Hoon Suk Park,&nbsp;Tae Hyun Ban,&nbsp;Seung Boo Yang,&nbsp;Young joo Kwon,&nbsp;the vascular access working group of the Korean Society of Dialysis Access","doi":"10.1111/hdi.13077","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Introduction</h3>\n \n <p>As nearly half of patients with end-stage kidney disease (ESKD) who initiate hemodialysis (HD) are over 65 years old (commonly defined as elderly), the fistula first strategy is controversial even in HD patients ≥65 years.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>In Korea's National Health Insurance Service database from 2008 to 2019, 41,989 elderly (≥ 65 years) HD patients were retrospectively reviewed to identify their clinical characteristics and outcomes. Vascular access (VA) patencies, risk factors associated with patencies and patient survival between arteriovenous fistula (AVF) and arteriovenous graft (AVG) were compared.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Elderly AVF group (n = 28,467) had superior primary, primary assisted, and secondary patencies than elderly AVG group (n = 13,522) (all <i>p</i> values are &lt;0.001). Patient survival was also better in the elderly AVF group than in the elderly AVG (<i>p</i> &lt; 0.001). In multivariate Cox regression analyses for diverse outcomes, AVG (vs. AVF) was identified as a risk factor for all-cause mortality (adjusted hazard ratio [HR]: 1.307; 95% confidence interval [CI]: 1.272–1.343; <i>p</i> &lt; 0.001), primary patency (adjusted HR: 1.745; 95% CI: 1.701–1.790; <i>p</i> &lt; 0.001), primary-assisted patency (adjusted HR: 2.163; 95% CI: 2.095–2.233; <i>p</i> &lt; 0.001), and secondary patency (adjusted HR: 3.718; 95% CI: 3.533–3.913; <i>p</i> &lt; 0.001).</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>Our study demonstrated that as a permanent VA for HD, AVF should be strongly considered in elderly (≥ 65 years) ESKD Korean patients. The age limit for AVF creation in ESKD patients should be adjusted more upward.</p>\n </section>\n </div>","PeriodicalId":1,"journal":{"name":"Accounts of Chemical Research","volume":null,"pages":null},"PeriodicalIF":16.4000,"publicationDate":"2023-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Evaluation of outcomes with permanent vascular access in an elderly Korean population based on the National Health Insurance Service database\",\"authors\":\"Hyangkyoung Kim,&nbsp;Hoon Suk Park,&nbsp;Tae Hyun Ban,&nbsp;Seung Boo Yang,&nbsp;Young joo Kwon,&nbsp;the vascular access working group of the Korean Society of Dialysis Access\",\"doi\":\"10.1111/hdi.13077\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Introduction</h3>\\n \\n <p>As nearly half of patients with end-stage kidney disease (ESKD) who initiate hemodialysis (HD) are over 65 years old (commonly defined as elderly), the fistula first strategy is controversial even in HD patients ≥65 years.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>In Korea's National Health Insurance Service database from 2008 to 2019, 41,989 elderly (≥ 65 years) HD patients were retrospectively reviewed to identify their clinical characteristics and outcomes. Vascular access (VA) patencies, risk factors associated with patencies and patient survival between arteriovenous fistula (AVF) and arteriovenous graft (AVG) were compared.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>Elderly AVF group (n = 28,467) had superior primary, primary assisted, and secondary patencies than elderly AVG group (n = 13,522) (all <i>p</i> values are &lt;0.001). Patient survival was also better in the elderly AVF group than in the elderly AVG (<i>p</i> &lt; 0.001). In multivariate Cox regression analyses for diverse outcomes, AVG (vs. AVF) was identified as a risk factor for all-cause mortality (adjusted hazard ratio [HR]: 1.307; 95% confidence interval [CI]: 1.272–1.343; <i>p</i> &lt; 0.001), primary patency (adjusted HR: 1.745; 95% CI: 1.701–1.790; <i>p</i> &lt; 0.001), primary-assisted patency (adjusted HR: 2.163; 95% CI: 2.095–2.233; <i>p</i> &lt; 0.001), and secondary patency (adjusted HR: 3.718; 95% CI: 3.533–3.913; <i>p</i> &lt; 0.001).</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusion</h3>\\n \\n <p>Our study demonstrated that as a permanent VA for HD, AVF should be strongly considered in elderly (≥ 65 years) ESKD Korean patients. The age limit for AVF creation in ESKD patients should be adjusted more upward.</p>\\n </section>\\n </div>\",\"PeriodicalId\":1,\"journal\":{\"name\":\"Accounts of Chemical Research\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":16.4000,\"publicationDate\":\"2023-03-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Accounts of Chemical Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/hdi.13077\",\"RegionNum\":1,\"RegionCategory\":\"化学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, MULTIDISCIPLINARY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Accounts of Chemical Research","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/hdi.13077","RegionNum":1,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0

摘要

由于近一半开始进行血液透析(HD)的终末期肾病(ESKD)患者年龄超过65岁(通常定义为老年人),因此即使在≥65岁的HD患者中,瘘管优先策略也存在争议。方法对2008年至2019年韩国国民健康保险服务数据库中41989例老年(≥65岁)HD患者进行回顾性分析,以确定其临床特征和结局。比较动静脉瘘(AVF)和动静脉移植物(AVG)的血管通路(VA)通畅度、相关危险因素及患者生存率。结果老年AVF组(n = 28,467)的原发性、原发性辅助和继发性通畅率均高于老年AVG组(n = 13,522) (p值均为<0.001)。老年AVF组患者生存率也高于老年AVG组(p < 0.001)。在多种结局的多变量Cox回归分析中,AVG (vs. AVF)被确定为全因死亡的危险因素(校正危险比[HR]: 1.307;95%置信区间[CI]: 1.272-1.343;p < 0.001),原发性通畅(调整后HR: 1.745;95% ci: 1.701-1.790;p < 0.001),原发性辅助通畅(调整后风险比:2.163;95% ci: 2.095-2.233;p < 0.001)和继发性通畅(调整后HR: 3.718;95% ci: 3.533-3.913;p < 0.001)。结论:我们的研究表明,对于老年(≥65岁)韩国ESKD患者,应强烈考虑AVF作为HD的永久性VA。ESKD患者产生AVF的年龄限制应该向上调整。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Evaluation of outcomes with permanent vascular access in an elderly Korean population based on the National Health Insurance Service database

Introduction

As nearly half of patients with end-stage kidney disease (ESKD) who initiate hemodialysis (HD) are over 65 years old (commonly defined as elderly), the fistula first strategy is controversial even in HD patients ≥65 years.

Methods

In Korea's National Health Insurance Service database from 2008 to 2019, 41,989 elderly (≥ 65 years) HD patients were retrospectively reviewed to identify their clinical characteristics and outcomes. Vascular access (VA) patencies, risk factors associated with patencies and patient survival between arteriovenous fistula (AVF) and arteriovenous graft (AVG) were compared.

Results

Elderly AVF group (n = 28,467) had superior primary, primary assisted, and secondary patencies than elderly AVG group (n = 13,522) (all p values are <0.001). Patient survival was also better in the elderly AVF group than in the elderly AVG (p < 0.001). In multivariate Cox regression analyses for diverse outcomes, AVG (vs. AVF) was identified as a risk factor for all-cause mortality (adjusted hazard ratio [HR]: 1.307; 95% confidence interval [CI]: 1.272–1.343; p < 0.001), primary patency (adjusted HR: 1.745; 95% CI: 1.701–1.790; p < 0.001), primary-assisted patency (adjusted HR: 2.163; 95% CI: 2.095–2.233; p < 0.001), and secondary patency (adjusted HR: 3.718; 95% CI: 3.533–3.913; p < 0.001).

Conclusion

Our study demonstrated that as a permanent VA for HD, AVF should be strongly considered in elderly (≥ 65 years) ESKD Korean patients. The age limit for AVF creation in ESKD patients should be adjusted more upward.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Accounts of Chemical Research
Accounts of Chemical Research 化学-化学综合
CiteScore
31.40
自引率
1.10%
发文量
312
审稿时长
2 months
期刊介绍: Accounts of Chemical Research presents short, concise and critical articles offering easy-to-read overviews of basic research and applications in all areas of chemistry and biochemistry. These short reviews focus on research from the author’s own laboratory and are designed to teach the reader about a research project. In addition, Accounts of Chemical Research publishes commentaries that give an informed opinion on a current research problem. Special Issues online are devoted to a single topic of unusual activity and significance. Accounts of Chemical Research replaces the traditional article abstract with an article "Conspectus." These entries synopsize the research affording the reader a closer look at the content and significance of an article. Through this provision of a more detailed description of the article contents, the Conspectus enhances the article's discoverability by search engines and the exposure for the research.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信